ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney/liver transplantation"

  • 2018 American Transplant Congress

    Delayed Graft Function in Simultaneous Liver Kidney Transplantation

    S. Weeks,1 X. Luo,1 S. Ottmann,1 A. Gurakar,2 F. Naqvi,2 B. Philosophe,1 A. Cameron,1 N. Desai,1 D. Segev,1 J. Garonzik Wang.1

    1Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD; 2Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

    Purpose: Increased rates of delayed graft function (DGF) after simultaneous liver kidney (SLK) transplantation have been described, as well as inferior graft survival in patients…
  • 2018 American Transplant Congress

    Excellent Outcomes for HCV-Viremic Recipients of Simultaneous Liver-Kidney Transplant in the Direct Anti-Viral Era

    A. Ray, C. Klein, T. Ommert, R. Cross, R. Rubin.

    Piedmont Transplant Institute, Piedmont Healthcare, Atlanta, GA.

    Before the era of direct anti-viral agents (DAAs), outcomes for HCV-viremic recipients of simultaneous liver kidney transplant (SLKT) were inferior to HCV-negative recipients. PURPOSE: To…
  • 2017 American Transplant Congress

    Sequential Liver-Kidney Transplantation Is Equivalent to Simultaneous Liver–Kidney Transplantation in Candidates Requiring Dialysis Pre-Transplant.

    M. Mulvihill, B. Yerokun, R. Davis, K. Anderson, M. Hartwig, A. Barbas.

    Surgery, Duke University Medical Center, Durham, NC

    Introduction: Liver transplant is the optimal therapy for patients with end-stage liver disease (ESLD). Appropriately-selected candidates with renal impairment benefit from transplantation of liver and…
  • 2017 American Transplant Congress

    Knowledge and Attitudes Associated with Willingness to Accept HIV+ Organs Among Persons Living with HIV.

    S. Anjum, S. Halpern, K. Kumar, A. Nyugen, S. Rasmussen, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.

    Surgery, Johns Hopkins, Baltimore

    HIV-to-HIV organ transplants are a novel treatment for organ failure in HIV-positive (HIV+) individuals. However, attitudes of potential HIV+ recipients regarding HIV+ donors remain unknown.Methods:…
  • 2017 American Transplant Congress

    Life Confocal Imaging of Murine Liver Biopsies as Novel Tool to Assess Graft Viability Prior to Transplantation.

    R. Oberhuber, M. Fodor, B. Cardini, M. Maglione, M. Hermann, J. Troppmaier.

    Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria

    Prolonged ischemia time due to organ procurement and transport are main contributors to a decrease in organ quality, which is further enhanced during reperfusion. This…
  • 2017 American Transplant Congress

    Hepatitis E Virus-Associated Cryoglobulinemia in Solid-Organ-Transplant Recipients: A Prospective Study.

    O. Marion,1 F. Abravanel,2 L. Esposito,1 S. Lhomme,2 A. Del Bello,1 J. Izopet,2 N. Kamar.1

    1Nephrology and Organ Transplant Unit, CHU Rangueil, Toulouse, France; 2Laboratory of Virology, CHU Purpan, Toulouse, France

    Hepatitis E virus (HEV) is responsible for acute and chronic autochthonous hepatitis in developed countries, particularly in Western Europe. Conversely to hepatitis B or C,…
  • 2017 American Transplant Congress

    Urine Biomarkers (UBio) Correlate Poorly with Pre-Liver Transplant (LT) Kidney Biopsy Findings and Post-LT Kidney Function.

    H. Wadei,1 J. Belcher,2 C. Parikh,2 T. Gonwa,1 M. Mai,1 J. Lieske.3

    1Transplant, Mayo Clinic, Jacksonville, FL; 2Medicine, Section of Nephrology, Yale University, New Haven, CT; 3Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN

    UBio might be valuable in determining the etiology of renal dysfunction in LT candidates.Aim: Correlate UBio with pre-LT kidney biopsy and post-LT kidney function.Methods:78 LT…
  • 2017 American Transplant Congress

    How Much Is a Kidney Worth? Comparing Kidney Transplant Strategies in Liver Transplant Candidates.

    X. Cheng,1 W. Kim,2 J. Tan,1 J. Goldhaber-Fiebert.3

    1Div Nephrology, ; 2Div Gastroenterology & Hepatology, ; 3Ctr Health Policy, Stanford U, Palo Alto

    The number of simultaneous liver-kidney (SLK) transplants for renal failure complicating end-stage liver disease (ESLD) is rising. The Organ Procurement and Transplant Network (OPTN) will…
  • 2017 American Transplant Congress

    Evaluation of the Conversion from Brand Name to Generic Immunosuppression in Hospitalized Organ Transplant Recipients.

    L. DeZotell,1 K. Blunck,1 J. Guy,1 M. Woods,1 M. Reffett,2 J. Terrell,2 A. Palermo,2 K. Gosch,3 L. Cummings.4

    1Department of Pharmacy, Saint Luke's Hospital, Kansas City, MO; 2Transplant Quality Department, Saint Luke's Hospital, Kansas City, MO; 3Cardiovascular Outcomes Research, Saint Luke's Hospital, Kansas City, MO; 4Abdominal Transplant and HPB Surgery, Saint Luke's Transplant Specialists, Kansas City, MO

    Purpose: Safe and effective immunosuppressant medications are critical to accomplish good graft and patient survival rates. The availability of “AB-rated” generic immunosuppression affords the opportunity…
  • 2017 American Transplant Congress

    Current Practice and Center-Level Variation in Simultaneous Liver-Kidney Listing.

    X. Luo, A. Massie, J. Garonzik-Wang, R. Choudhury, A. Shaffer, S. Zhou, D. Segev.

    Johns Hopkins, Baltimore, MD

    The OPTN has proposed medical eligibility criteria to determine which transplant candidates are appropriate for SLK vs liver-alone transplantation. We investigated center variation of SLK…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 24
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences